
Haleon is an independent publicly traded company, not owned by a parent. It listed on the London Stock Exchange and NYSE in July 2022 after GSK demerged its consumer healthcare division, which had already absorbed Pfizer's consumer business in 2019. Haleon trades under ticker HLN and is headquartered in Weybridge, Surrey, United Kingdom.
Parent Company
Founded
2022
Status
Publicly Traded
Headquarters
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Haleon | Haleon plc | Brand division |
The Haleon name is new, but its businesses are among the oldest in consumer health. The corporate lineage combines GSK's consumer brands, some dating to the 1800s, with Pfizer's consumer healthcare division, which brought brands including Advil, Centrum, Caltrate, and ChapStick into the joint venture.
The structural formation began in December 2018, when GSK and Pfizer agreed to merge their consumer health businesses into a joint venture owned 68 percent by GSK and 32 percent by Pfizer. That combination closed in July 2019, creating the world's largest consumer health company by revenue. GSK then announced in 2021 that it would demerge the joint venture as a separately listed company.
Haleon plc debuted on the London Stock Exchange on July 18, 2022, taking the name from "hale," an old English word for health, and "leon," suggesting strength. GSK distributed the bulk of shares to its own investors, retained a stake that it sold through 2023, and Pfizer held its roughly 32 percent position before beginning a phased exit announced in 2023 and largely completed through secondary sales by 2025.
Under CEO Brian McNamara, the company has run a strategy of portfolio focus and margin improvement. It has divested smaller or non-core brands and geographies, concentrated investment behind a set of power brands, and guided to mid-single-digit revenue growth. FY2025 net revenue reached approximately GBP 10.2 billion.
What does Haleon own?
Haleon owns a portfolio of approximately 24 global and regional consumer health brands across five categories: oral health, vitamins and supplements, pain relief, respiratory health, and digestive health. Key brands include Sensodyne, Panadol, Centrum, Advil, Voltaren, Otrivin, Parodontax, Polident and Poligrip, Aquafresh, and Emergen-C. Products are sold in more than 170 countries.
Is Haleon publicly traded?
Yes. Haleon plc is listed on the London Stock Exchange under ticker HLN, with American Depositary Shares also listed on the New York Stock Exchange under the same ticker. Haleon completed its listing on the London Stock Exchange on July 18, 2022, in what was the largest London Stock Exchange listing in over a decade. The company does not have a controlling shareholder.
Who founded Haleon?
Haleon was formed through the demerger of GSK's consumer healthcare division in July 2022 and does not have a traditional founder. The consumer healthcare business that became Haleon was assembled by GSK and Pfizer through decades of acquisitions. In 2019, GSK and Pfizer combined their consumer healthcare businesses into a joint venture, which was subsequently demerged as Haleon in 2022. Brian McNamara became CEO at the time of the demerger.
Where is Haleon headquartered?
Haleon is headquartered in Weybridge, Surrey, United Kingdom. The company's registered office and principal executive offices are located in Weybridge. Haleon operates manufacturing facilities in the United Kingdom, the United States, India, Germany, Ireland, and China. The company sells products in more than 170 countries.
How many brands does Haleon own?
Haleon owns approximately 24 global and regional consumer health brands. The portfolio is concentrated in five categories: oral health (Sensodyne, Parodontax, Polident, Poligrip, Aquafresh), vitamins and supplements (Centrum, Caltrate, Emergen-C), pain relief (Advil, Panadol, Voltaren), respiratory health (Otrivin, Theraflu, Robitussin), and digestive health (Nexium Control, Tums).
Who owns Haleon?
Haleon plc is a publicly traded company with no controlling shareholder. At the time of the July 2022 demerger, GSK plc and Pfizer Inc. each retained significant stakes in Haleon. Both companies have been reducing their positions through secondary share placements. As of early 2026, both GSK and Pfizer have substantially reduced their stakes, each holding less than 10% of shares. The remaining shares are held by institutional investors and public shareholders.
What is Haleon's revenue?
Haleon reported FY2025 net revenue of approximately GBP 10.2 billion, with organic revenue growth of approximately 4%. The oral health category is the largest and fastest-growing segment, driven by Sensodyne. The company employs approximately 24,000 people and sells products in more than 170 countries.
Haleon's controversy record is largely inherited product-level matters rather than corporate misconduct. In 2023, its Theraflu and other GSK-legacy products were swept into the US FDA's ruling that oral phenylephrine is ineffective as a decongestant, affecting formulations across the industry rather than Haleon alone.
The company has also managed routine consumer health recalls and the post-demerger task of exiting shareholder relationships with former parents. Litigation inherited from GSK consumer health matters, including legacy product claims, remains part of its risk profile as disclosed in annual filings.
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Cimed | Brazil | 1977 | Mass market | Latin america | All Genders | |
| Bayer Ag | USA | 1993 | Mass market | Global | All Genders |
Healthcare PharmaceuticalsOwned by Cimed & Co.
Brazilian pharmaceutical and consumer health company founded in 1977, one of Brazil's largest drugmakers, known for Carmed, Cimegripe, and Lavitan.
Healthcare PharmaceuticalsOwned by Bayer AG
Over-the-counter allergy relief brand containing loratadine, originally developed by Schering-Plough and first approved by the FDA in 1993. Owned by Bayer AG since its 2014 acquisition of Merck's consumer care business for $14.2 billion.
Market Positioning: Haleon competes with 2 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Looking for brands with different ownership structures? These similar brands are not owned by Haleon plc, giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsOwned by Cimed & Co.
Brazilian pharmaceutical and consumer health company founded in 1977, one of Brazil's largest drugmakers, known for Carmed, Cimegripe, and Lavitan.
Cimed is privately owned, unlike Haleon which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Adcock Ingram Holdings Limited
South African pharmaceutical brand behind Panado and Myprodol, now privately held by Bidvest and NATCO Pharma.
Adcock Ingram is privately owned, unlike Haleon which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Alfa-Pharm CJSC
Armenia's largest pharmaceutical distributor and pharmacy chain, importing medicines from more than 70 global manufacturers since 1996.
Alfa-Pharm is privately owned, unlike Haleon which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Opella
Over-the-counter allergy relief brand containing fexofenadine, originally developed by Hoechst Marion Roussel and approved by the FDA in 1996. Owned since April 2025 by Opella, the consumer healthcare company carved out of Sanofi and controlled by Clayton, Dubilier and Rice.
Allegra is privately owned, unlike Haleon which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Kenvue
American adhesive bandage brand invented in 1921, owned by Kenvue Inc. Band-Aid is the leading adhesive bandage brand in the United States and is sold in more than 100 countries.
Band-Aid is privately owned, unlike Haleon which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Boehringer Ingelheim
German family-owned pharmaceutical brand behind Jardiance and Spiriva, founded in 1885 and still controlled by the Boehringer family.
Boehringer Ingelheim is privately owned, unlike Haleon which is under a publicly traded parent company.
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Consumer DNA testing brand now run as a nonprofit under TTAM Research Institute following the 2025 bankruptcy sale of 23andMe Holding Co.

Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.

Abbott Laboratories' medical device business spanning cardiovascular, diabetes care (FreeStyle Libre), neuromodulation, and structural heart, generating roughly $20 billion annually.